(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.31%) $82.75
(6.34%) $2.05
(0.04%) $2 348.10
(-0.21%) $27.48
(3.91%) $958.15
(-0.22%) $0.933
(-0.34%) $10.99
(-0.55%) $0.796
(1.66%) $93.40
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 14.14%
Live Chart Being Loaded With Signals
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico...
Stats | |
---|---|
今日成交量 | 8 197.00 |
平均成交量 | 50 182.00 |
市值 | 9.34M |
EPS | $0 ( 2024-02-22 ) |
下一个收益日期 | ( $0 ) 2024-05-01 |
Last Dividend | $1 728.00 ( 2007-03-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.750 |
ATR14 | $0.0460 (0.98%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-18 | Horowitz Joshua | Buy | 16 438 | Common Stock |
2024-04-18 | Horowitz Joshua | Buy | 0 | Common Stock |
2024-04-18 | Horowitz Joshua | Sell | 0 | Common Stock |
2024-04-01 | Higgins Thomas T | Buy | 469 | Common Stock |
2024-04-01 | Higgins Thomas T | Sell | 74 | Common Stock |
INSIDER POWER |
---|
54.21 |
Last 97 transactions |
Buy: 971 558 | Sell: 254 579 |
NeuroMetrix Inc 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
NeuroMetrix Inc 财务报表
Annual | 2023 |
营收: | $5.90M |
毛利润: | $3.95M (66.89 %) |
EPS: | $-6.27 |
FY | 2023 |
营收: | $5.90M |
毛利润: | $3.95M (66.89 %) |
EPS: | $-6.27 |
FY | 2022 |
营收: | $8.26M |
毛利润: | $5.75M (69.65 %) |
EPS: | $-4.90 |
FY | 2021 |
营收: | $8.25M |
毛利润: | $5.92M (71.75 %) |
EPS: | $-0.342 |
Financial Reports:
No articles found.
NeuroMetrix Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $1 728.00 | 2007-03-28 |
Last Dividend | $1 728.00 | 2007-03-28 |
Next Dividend | $0 | N/A |
Payout Date | 2007-04-13 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $1 728.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.01 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2007 | $1.000 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -1.083 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.298 | 1.200 | -9.95 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.307 | 1.500 | -4.52 | -6.78 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 16.81 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 14.92 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.396 | 1.500 | 3.36 | 5.03 | [0.2 - 2] |
debtRatioTTM | 0.0112 | -1.500 | 9.81 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 52.63 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -3.99 | 2.00 | -1.330 | -2.66 | [0 - 30] |
freeCashFlowPerShareTTM | -4.11 | 2.00 | -2.06 | -4.11 | [0 - 20] |
debtEquityRatioTTM | 0.0120 | -1.500 | 9.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.669 | 1.000 | 2.19 | 2.19 | [0.2 - 0.8] |
operatingProfitMarginTTM | -1.212 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -25.26 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.275 | 0.800 | -1.497 | -1.198 | [0.5 - 2] |
Total Score | -0.253 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -1.059 | 1.000 | -0.208 | 0 | [1 - 100] |
returnOnEquityTTM | -0.307 | 2.50 | -2.90 | -6.78 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -4.11 | 2.00 | -1.370 | -4.11 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -3.99 | 2.00 | -1.330 | -2.66 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0361 | 1.500 | -3.57 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -1.031 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -2.82 |
NeuroMetrix Inc
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。